Seeking Alpha
 

Ligand Pharmaceuticals Incorporated (LGND)

- NASDAQ
  • FitzWonder | Send Message 5h

    $LGND Who's going to the Williams School reunion?
    Reply
      • Jim Van Meerten | Send Message 27 Apr

        $LGND - 96% Barchart technical buy signals - 14 new highs and up 23.76% in the last month - Relative Strength Index 75.67%
        Reply
          • Jim Van Meerten | Send Message 27 Apr

            5 Breakout Small Caps $LGND, $HSTM, $IPCM http://seekingalpha.com/p/2ckbq
            Reply
              • timtrading | Send Message 20 Mar
                Reply
                  • Lowenthal Capital Partners | Send Message 3 Mar

                    Ligand Pharmaceuticals Weakens The Bear Case $LGND http://seekingalpha.com/a/1rmjm
                    Reply
                      • Chris Katje | Send Message 10 Feb

                        Ligand Pharmaceuticals Had Strong 2014, Shares Barely Moved, Time To Act $LGND http://seekingalpha.com/a/1q8wo
                        Reply
                          • Clinically Sound Investor | Send Message 29 Jan

                            Earnings Peek: Stay With Ligand Pharmaceuticals For A Year Or Three $LGND http://seekingalpha.com/a/1pf1y
                            Reply
                              • LaboMedic | Send Message 9 Jan

                                $LGND Roth Capital Comments On Ligand Pharmaceuticals Ahead Of 4Q14 Results http://bit.ly/1tTwGxv
                                Reply
                                  • Lowenthal Capital Partners | Send Message 8 Jan

                                    Update: Ligand Partner Moves Closer To Delafloxacin Launch $LGND http://seekingalpha.com/a/1o6fj
                                    Reply
                                      • Lowenthal Capital Partners | Send Message 28 Dec 2014

                                        Update: Ligand Announces Key Regulatory Submissions $LGND http://seekingalpha.com/a/1nne9
                                        Reply
                                          Visit Seeking Alpha's
                                          LGND vs. ETF Alternatives
                                          Company Description
                                          Ligand Pharmaceuticals Incis a biopharmaceutical company with a business model that is based upon the concept of developing or acquiring royalty revenue generating assets and coupling them with a lean corporate cost structure.
                                          Sector: Healthcare
                                          Industry: Biotechnology
                                          Country: United States